Announce Date | 04/22/2025 |
EPS Normalized Actual | $0.46 (Miss by $-0.15) |
EPS GAAP Actual | $0.46 (Miss by $-0.15) |
Revenue Actual | $1.459B |
Revenue Surprise | Beat by $1459M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.76744 |
EPS GAAP Estimate | $2.76744 |
Revenue Estimate | $1.6832956B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 14.73663 | 5.06 | 13.97009 | 15.45568 | 0 |
Dec 2027 | 12.41401 | 6.01 | 11.76829 | 13.01973 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.53 | 0.53 | 1.459B | -51.05% | 1459M |
FQ4 2024 (Dec 2024) | -0.78 | -0.78 | 1.405B | -7.76% | 1405M |
FQ3 2024 (Sep 2024) | -1.04 | -1.04 | 1.44856B | -17.7% | 1448.56M |
FQ2 2024 (Jun 2024) | 1.29 | 1.29 | 1.70465B | 5.67% | 1704.65M |
FQ1 2024 (Mar 2024) | 0.57 | 0.57 | 2.20384B | 26.17% | 2203.84M |
FQ4 2023 (Dec 2023) | 0 | 0 | 1.514B | -6.74% | 1514M |
FQ3 2023 (Sep 2023) | 1.91 | 1.91 | 1.705B | -22.46% | 1705M |
FQ2 2023 (Jun 2023) | -1.57 | -1.57 | 1.608B | -79.54% | 1608M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.76744
Consensus Revenue Estimates
1.6832956B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.5766 | -- | 1.49127 | 1.66193 | 1 |
FQ3 2027 (Sep 2027) | 3.68731 | -- | 3.48774 | 3.88688 | 1 |
FQ2 2027 (Jun 2027) | 4.51599 | -- | 4.27157 | 4.76041 | 1 |
FQ1 2027 (Mar 2027) | 4.30752 | -- | 4.07439 | 4.54065 | 1 |
FQ4 2026 (Dec 2026) | 0.0133484 | -- | 0.01280668 | 0.01372157 | 0 |
FQ3 2026 (Sep 2026) | 1.97556 | -- | 1.89539 | 2.03079 | 0 |
FQ2 2026 (Jun 2026) | 2.49615 | -- | 2.39485 | 2.56593 | 0 |
FQ1 2026 (Mar 2026) | 2.0957 | 74.71 | 2.01065 | 2.15429 | 0 |
FQ4 2025 (Dec 2025) | 2.28258 | 134.17 | 2.18995 | 2.34639 | 2 |
FQ3 2025 (Sep 2025) | 2.76744 | 137.58 | 2.62605 | 2.93713 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.65B | -- | 1.58B | 1.72B | 1 |
FQ3 2027 (Sep 2027) | 1.87B | -- | 1.8B | 1.95B | 1 |
FQ2 2027 (Jun 2027) | 1.92B | -- | 1.84B | 2B | 1 |
FQ1 2027 (Mar 2027) | 1.84B | -- | 1.76B | 1.92B | 1 |
FQ4 2026 (Dec 2026) | 1.56B | -- | 1.51B | 1.59B | 1 |
FQ3 2026 (Sep 2026) | 1.77B | -- | 1.72B | 1.81B | 1 |
FQ2 2026 (Jun 2026) | 1.84B | -- | 1.79B | 1.88B | 1 |
FQ1 2026 (Mar 2026) | 1.74B | 16.14 | 1.69B | 1.78B | 1 |
FQ4 2025 (Dec 2025) | 1.64B | 14.42 | 1.59B | 1.68B | 1 |
FQ3 2025 (Sep 2025) | 1.68B | 13.95 | 1.62B | 1.76B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.53 | 0.53 | 100% | |
FQ4 2024 (Dec 2024) | -0.78 | -0.78 | 100% | |
FQ3 2024 (Sep 2024) | -1.04 | -1.04 | 100% | |
FQ2 2024 (Jun 2024) | 1.29 | 1.29 | 100% | |
FQ1 2024 (Mar 2024) | 0.57 | 0.57 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.91 | 1.91 | 100% | |
FQ2 2023 (Jun 2023) | -1.57 | -1.57 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.46B | $1459M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.41B | $1405M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.45B | $1448.56M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.7B | $1704.65M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.2B | $2203.84M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.51B | $1514M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.71B | $1705M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.61B | $1608M | 100% |